Search

everythinglearnresearchcommunity

for

Search:↓

A 17-year-old girl had severe, on-and-off hair loss, likely due to COVID-19. She was treated with Vitamin D3, biotin, and other supplements, and saw some improvement within a month.

Treating post-COVID hair loss leads to full recovery, while not treating it often results in ongoing symptoms.

Telogen Effluvium (TE) significantly affects women due to stress and hormonal changes, requiring better public health policies and mental health support.

COVID-19 may be linked to hair loss called Telogen Effluvium, affecting quality of life and self-esteem.

Telogen effluvium is common after symptomatic COVID-19, especially in young females, and may be linked to nutritional deficiencies.

COVID-19 can cause hair loss in both severe and mild cases, often affecting women.

Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.

The document cannot be parsed.

A unified approach is needed to better diagnose and manage Telogen Effluvium, focusing on education, empathy, and safe treatments.

Most lab tests for patients with Telogen effluvium, a type of hair loss, show no or mild abnormalities; only a few specific tests are useful.

A woman recovered from hair loss and skin eruptions after stopping a tuberculosis drug and using steroids.

A woman's use of minoxidil for hair loss caused fluid buildup in her chest, which went away when she stopped using the product.

People with Telogen Effluvium have lower vitamin D levels.

A woman's COVID-19 related hair loss improved after using a specific hair care routine for 30 days.

A patient's hair loss after a browlift surgery improved on its own over 8 months.

COVID-19 may cause hair loss due to infection stress or treatments.

A woman's sudden hair loss was linked to azathioprine use despite normal enzyme levels, and improved after stopping the drug and starting treatment.

The document concludes that we need more research to understand Telogen Effluvium and find effective treatments.

Chronic hair shedding may be caused by less variation in hair growth times and might stop on its own after several years.

COVID-19 may cause temporary hair loss in some people.

COVID-19 recovery can lead to temporary hair loss called telogen effluvium.

A standardized guideline would improve Telogen Effluvium management.

Weight loss can cause temporary hair loss, especially in women and older adults.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.

The study concludes that traction alopecia, caused by hair styling, can help understand telogen effluvium, a condition of excessive hair loss.

COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.

Hair loss (telogen effluvium) cases rose during the pandemic, especially in Hispanic and non-White groups, and were linked to other health issues and COVID-19.